Type II NADH:Menaquinone Oxidoreductase of Mycobacterium tuberculosis

Publisher： Bentham Science Publishers

E-ISSN： 2212-3989|7|2|169-181

ISSN： 1871-5265

Source： Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.7, Iss.2, 2007-06, pp. : 169-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-and-Mechanism-Based Design and Discovery of Type II Mycobacterium Tuberculosis Dehydroquinate Dehydratase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 1, 2014-01 ,pp. : 51-63

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Iron Acquisition by Mycobacterium tuberculosis

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 3, 2007-01 ,pp. : 213-220

Bentham Science Publishers

Access to resources Recommend Favorite

In Search of Drug Targets for Mycobacterium tuberculosis

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 3, 2007-09 ,pp. : 245-250

Bentham Science Publishers

Access to resources Recommend Favorite

Pyrimidine Salvage Pathway in Mycobacterium tuberculosis

By  

Current Medicinal Chemistry, Vol. 18, Iss. 9, 2011-03 ,pp. : 1286-1298

Bentham Science Publishers

Access to resources Recommend Favorite

Purine Salvage Pathway in Mycobacterium tuberculosis

By  

Current Medicinal Chemistry, Vol. 18, Iss. 9, 2011-03 ,pp. : 1258-1275

Bentham Science Publishers

Access to resources Recommend Favorite